BioNTech Aktie
WKN DE: A2PSR2 / ISIN: US09075V1026
|
03.11.2025 13:13:03
|
BioNTech Boosts FY25 Revenue Outlook - Update
(RTTNews) - While reporting financial results for the third quarter on Monday, immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) said it now expects revenues for the full-year 2025 to be between 2.6 billion and 2.8 billion euros, up from the prior forecast range between 1.7 billion to 2.2 billion euros.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioNTech (ADRs)mehr Nachrichten
Analysen zu BioNTech (ADRs)mehr Analysen
| 03.11.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 22.08.25 | BioNTech Neutral | UBS AG | |
| 05.08.25 | BioNTech Buy | Deutsche Bank AG | |
| 05.08.25 | BioNTech Neutral | UBS AG | |
| 05.08.25 | BioNTech Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| BioNTech (ADRs) | 88,75 | -1,00% |
|